Komori
Results3001Katakura Industries Co.,Ltd.Materials and Chemicals

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

For the nine months through the third quarter of the fiscal year ending December 2026, revenue fell below the year-earlier period due to lower revenue from the machinery-related business, while operating profit increased, mainly due to higher profit from the real estate and textile businesses. The full-year earnings forecast was left unchanged, but the annual dividend forecast was raised from ¥60 to ¥70.

Worth reading
49Recurring
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
10
¥/share
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAP
Net Sales29,851¥ millionYear on year -1.0%Progress 72.6%
Operating profit5,193¥ millionYear on year +8.1%Progress 89.5%
Ordinary income6,179¥ millionYear on year +7.7%Progress 85.8%
Net income attributable to owners of the parent6,443¥ millionYear on year +32.3%Progress 86.5%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥203.49
Financial position at period-end
Total assets154,714¥ million
of which net assets 104,128 ¥ millionEquity ratio 65.9%vs. prior year-end +2.1pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueReal Estate ¥9,080 million (YoY +4.5%), Pharmaceuticals ¥8,856 million (YoY +5.3%), Machinery-related ¥4,802 million (YoY -22.8%), Textiles ¥5,119 million (YoY +5.7%), Other ¥1,992 million (YoY +1.0%)
Segment profitReal Estate ¥3,817 million (YoY +10.6%), Pharmaceuticals ¥723 million (YoY -11.8%), Machinery-related ¥388 million (YoY -45.8%), Textiles ¥835 million (YoY +68.0%), Other ¥87 million (YoY +81.5%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥41,100 million (YoY +1.1%)
Operating profit¥5,800 million (YoY -0.9%)
Ordinary income¥7,200 million (YoY -0.2%)
Net income¥7,450 million (YoY +29.3%)
Annual Dividend Forecast60 Yen → 70 Yen
Factors Behind Changes in Business Performance

Revenue declined due to lower revenue from the machinery-related business, despite higher revenue from the real estate and pharmaceutical businesses, among others. Operating profit increased as higher profit from the real estate and textile businesses, among others, outweighed lower profit from the machinery-related and pharmaceutical businesses. Net profit increased mainly due to the recognition of gains on the sale of investment securities.

Disclosure regarding the going concern assumption

Not applicable

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name Not applicable
Material subsequent eventsNo applicable items
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥2,973 million / Extraordinary loss Loss on disposal of fixed assets ¥76 million
Depreciation and amortization¥2,156 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者:Not disclosed)
Issued Shares at Period-End35,215,000 Shares
Treasury Shares at Period-End3,543,011 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026–30 September 2026
Net Sales¥29,851 million (YoY -1.0%)
Operating profit¥5,193 million (YoY +8.1%)
Ordinary income¥6,179 million (YoY +7.7%)
Profit attributable to owners of the parent¥6,443 million (YoY +32.3%)
Net income per share¥203.49
Equity ratioEnd of the current fiscal period 65.9 / End of previous period 63.8
Total assets¥154,714 million
Net assets¥104,128 million
Full-year earnings forecastNet Sales ¥41,100 million (YoY +1.1%) / Operating profit ¥5,800 million (YoY -0.9%) / Ordinary income ¥7,200 million (YoY -0.2%) / Net income ¥7,450 million (YoY +29.3%)
Annual Dividend Forecast60 Yen → 70 Yen
Segment revenueReal Estate ¥9,080 million (YoY +4.5%), Pharmaceuticals ¥8,856 million (YoY +5.3%), Machinery-related ¥4,802 million (YoY -22.8%), Textiles ¥5,119 million (YoY +5.7%), Other ¥1,992 million (YoY +1.0%)
Segment profitReal Estate ¥3,817 million (YoY +10.6%), Pharmaceuticals ¥723 million (YoY -11.8%), Machinery-related ¥388 million (YoY -45.8%), Textiles ¥835 million (YoY +68.0%), Other ¥87 million (YoY +81.5%)
Depreciation and amortization¥2,156 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥2,973 million / Extraordinary loss Loss on disposal of fixed assets ¥76 million
Disclosure regarding the going concern assumptionNot applicable
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name Not applicable
Material subsequent eventsNo applicable items
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者:Not disclosed)
Issued Shares at Period-End35,215,000 Shares
Treasury Shares at Period-End3,543,011 Shares
Factors Behind Changes in Business PerformanceRevenue declined due to lower revenue from the machinery-related business, despite higher revenue from the real estate and pharmaceutical businesses, among others. Operating profit increased as higher profit from the real estate and textile businesses, among others, outweighed lower profit from the machinery-related and pharmaceutical businesses. Net profit increased mainly due to the recognition of gains on the sale of investment securities.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue declined due to lower revenue from the machinery-related business, despite higher revenue from the real estate and pharmaceutical businesses, among others. Operating profit increased, as higher profit from the real estate and textile businesses, among others, outweighed lower profit from the machinery-related and pharmaceutical businesses. Net profit attributable to owners of the parent increased, mainly due to the recognition of gains on the sale of investment securities. This brief report does not provide details on the reasons for revising the dividend forecast.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | Katakura Industries Co.,Ltd. (3001) timely disclosure | Komori